(Q28340422)

https://api.crossref.org/works/10.1111/J.1464-410X.1975.TB03998.X

22 October 2023

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1975.TB03998.X

22 October 2023

author name string

I. D. Ansell

1

1 reference

Europe PubMed Central

PubMed ID

1180990

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1180990

29 August 2022

J. E. Castro

2

1 reference

Europe PubMed Central

PubMed ID

1180990

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1180990

full work available at URL

29 August 2022

language of work or name

English

0 references

publication date

August 1975

0 references

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1464-410X.1975.tb03998.x

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1975.TB03998.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.1975.tb03998.x/fullpdf

22 October 2023

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1975.TB03998.X

British Journal of Urology

22 October 2023

published in

0 references

volume

47

0 references

page(s)

413-8

0 references

issue

4

0 references

cites work

Increased Oncogenic Effect of Methylcholanthrene after Treatment with Anti-lymphocyte Serum

1

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1975.TB03998.X

Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin

22 October 2023

3

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1975.TB03998.X

CYTOLOGICAL STUDY OF THE EFFECT OF CYCLOPHOSPHAMIDE ON THE EPITHELIUM OF THE URINARY BLADDER IN MAN

22 October 2023

5

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1975.TB03998.X

Immunological deficiency diseases

22 October 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1975.TB03998.X

Urinary-bladder fibrosis and telangiectasia associated with long-term cyclophosphamide therapy

22 October 2023

8

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1975.TB03998.X

Cyclophosphamide and urinary bladder toxicity

22 October 2023

16

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1975.TB03998.X

Cyclophosphamide hemorrhagic cystitis

22 October 2023

18

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1975.TB03998.X

EFFECT OF CYCLOPHOSPHAMIDE THERAPY ON THE URINARY SYSTEM

22 October 2023

19

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1975.TB03998.X

Renal transplantation under cyclophosphamide

22 October 2023

20

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1975.TB03998.X

Selective depletion of lymphoid tissue by cyclophosphamide

22 October 2023

22

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1975.TB03998.X

Urological Complications of Cyclophosphamide

22 October 2023

23

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1975.TB03998.X

Cyclophosphamide and the bladder

22 October 2023

24

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1975.TB03998.X

22 October 2023

Identifiers